Gs-5737    (DrugBank: -)

1 disease
IDDisease name (Link within this page)Number of trials
299Cystic fibrosis2

299. Cystic fibrosis    [ 1,592 clinical trials,   1,539 drugs,   (DrugBank: 255 drugs),   81 drug target genes,   162 drug target pathways]
Searched query = "Cystic fibrosis"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
2 / 1,592 trials found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT01840735
(ClinicalTrials.gov)
May 201315/4/2013Phase 1b Safety, Tolerability, and PK Study to Assess GS-5737 in Subjects With CFA Phase 1b, Randomized, Double-Blind, Placebo-Controlled, Single Dose Study to Assess the Safety, Tolerability, and Pharmacokinetics of GS-5737 in Subjects With Cystic FibrosisCystic FibrosisDrug: GS-5737;Drug: PlaceboGilead SciencesNULLCompleted18 YearsN/ABoth8Phase 1United States
2NCT01793649
(ClinicalTrials.gov)
October 201214/2/2013A Phase 1 Study to Characterize the Effect of GS-5737 Enhancement of Mucociliary Clearance (MCC) in Healthy SubjectsA Phase 1, Randomized, Double-Blind, Cross-Over, Vehicle-Controlled, Single-Dose Study To Characterize The Effect of GS-5737 Enhancement of Mucociliary Clearance (MCC) In Healthy SubjectsCystic Fibrosis;Chronic Obstructive Pulmonary DiseaseDrug: GS-5737Gilead SciencesNULLTerminated18 Years45 YearsBoth7Phase 1United States